Clinical protocol: phase I study of an adenovirus/prostate-specific antigen vaccine in men with metastatic prostate cancer

Hum Gene Ther. 2006 Feb;17(2):220-9. doi: 10.1089/hum.2006.17.220.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics
  • Cancer Vaccines / adverse effects
  • Cancer Vaccines / genetics
  • Cancer Vaccines / therapeutic use*
  • Clinical Protocols
  • Clinical Trials, Phase I as Topic
  • Dose-Response Relationship, Immunologic
  • Gelatin Sponge, Absorbable
  • Genetic Vectors / genetics
  • Humans
  • Male
  • Patient Selection
  • Prostate-Specific Antigen / genetics*
  • Prostate-Specific Antigen / immunology
  • Prostatic Neoplasms / immunology
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / therapy*

Substances

  • Cancer Vaccines
  • Prostate-Specific Antigen